NO311637B1 - Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer - Google Patents

Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer Download PDF

Info

Publication number
NO311637B1
NO311637B1 NO19970517A NO970517A NO311637B1 NO 311637 B1 NO311637 B1 NO 311637B1 NO 19970517 A NO19970517 A NO 19970517A NO 970517 A NO970517 A NO 970517A NO 311637 B1 NO311637 B1 NO 311637B1
Authority
NO
Norway
Prior art keywords
dimethylaminopropylidene
dihydrodibenz
oxepin
acetic acid
treatment
Prior art date
Application number
NO19970517A
Other languages
English (en)
Norwegian (no)
Other versions
NO970517D0 (no
NO970517L (no
Inventor
John Michael Yanni
Stella M Robertson
Eiji Hayakawa
Masashi Nakakura
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23864859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO311637(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO970517D0 publication Critical patent/NO970517D0/no
Publication of NO970517L publication Critical patent/NO970517L/no
Publication of NO311637B1 publication Critical patent/NO311637B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19970517A 1995-06-06 1997-02-05 Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer NO311637B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,729 US5641805A (en) 1995-06-06 1995-06-06 Topical ophthalmic formulations for treating allergic eye diseases
PCT/US1996/006289 WO1996039147A2 (en) 1995-06-06 1996-05-03 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases

Publications (3)

Publication Number Publication Date
NO970517D0 NO970517D0 (no) 1997-02-05
NO970517L NO970517L (no) 1997-04-03
NO311637B1 true NO311637B1 (no) 2001-12-27

Family

ID=23864859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970517A NO311637B1 (no) 1995-06-06 1997-02-05 Topiske oftalmiske formuleringer inneholdende doxepinderivater for behandling av öyenallergisykdommer

Country Status (20)

Country Link
US (1) US5641805A (de)
EP (1) EP0799044B1 (de)
JP (1) JP3068858B2 (de)
KR (1) KR100202155B1 (de)
CN (1) CN1082367C (de)
AT (1) ATE220906T1 (de)
AU (1) AU698854B2 (de)
CA (1) CA2195094C (de)
DE (2) DE10299034I2 (de)
DK (1) DK0799044T3 (de)
ES (1) ES2179198T3 (de)
FI (1) FI970489A0 (de)
LU (1) LU90969I2 (de)
MX (1) MX9701013A (de)
MY (1) MY116651A (de)
NL (1) NL300101I2 (de)
NO (1) NO311637B1 (de)
PT (1) PT799044E (de)
TW (1) TW438588B (de)
WO (1) WO1996039147A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859000A (en) * 1995-06-07 1999-01-12 University Of Utah Research Foundation Method for reducing mast cell mediated allergic reactions
PT1037627E (pt) * 1998-07-14 2001-11-30 Alcon Lab Inc Utilizacao do acido 11-(3-dimetilaminopropilideno)-6,11-dihidrodibenz¬b,e|oxepin-2-acetico e seus sais derivados farmaceuticamente aceitaveis para a producao de um medicamento para o tratamento de doencas inflamatorias oftalmicas nao-alergicas e para a prebencao da neovascularizacao ocular
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
DK1187617T3 (da) 1999-06-18 2004-04-13 Alcon Mfg Ltd Fremgangsmåde til at vælge koncentrationen af et amfipatisk antihistaminlægemiddel ved at bestemme lægemidlets overfladeaktivitetsmåltal
WO2001054687A1 (en) 2000-01-25 2001-08-02 Alcon Universal Ltd. Ophthalmic anti-allergy compositions suitable for use with contact lenses
ATE330938T1 (de) 2000-05-19 2006-07-15 Alcon Inc Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
ES2243482T3 (es) 2000-05-19 2005-12-01 Alcon Inc. Composiciones que contienen un derivado de disulfuro de benzamida para tratar enfermedades alergicas.
EP1289945B1 (de) 2000-05-19 2004-08-04 Alcon Inc. Anilin-disulfid-derivate zur behandlung allergischer erkrankungen
US20040146502A1 (en) * 2001-05-03 2004-07-29 Elisabeth Latour Use of organic compounds
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
ATE317268T1 (de) * 2001-12-05 2006-02-15 Alcon Inc Verwendung eines h1-antagonisten und von rimexolon als sicheres steroid zur behandlung von rhinitis
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
AU2005259911A1 (en) * 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
PL1814538T3 (pl) * 2004-11-24 2010-02-26 Alcon Inc Sposób dostarczania donosowego sprayu
EP1901708B1 (de) * 2005-07-08 2013-09-11 Senju Pharmaceutical Co., Ltd. Perkutan saugfähiges ophthalmisches präparat mit olopatadin
SG170044A1 (en) 2006-03-31 2011-04-29 Vistakon Pharmaceuticals Llc Ocular allergy treatments
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
WO2008097220A1 (en) 2007-02-07 2008-08-14 Alcon, Inc. Olopatadine formulations for topical nasal administration
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
EP2189157A4 (de) * 2007-09-06 2012-10-31 Kyowa Hakko Kirin Co Ltd AUGENTROPFEN MIT DIBENZO[b,e]OXEPIN-DERIVAT
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
IT1397503B1 (it) 2009-04-21 2013-01-16 F S I Fabbrica Italiana Sint Processo per la preparazione di olopatadina
BR112012001169A2 (pt) 2009-07-17 2016-03-01 Alcon Res Ltd sistema de pulverização nasal de olopatadina para crianças
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US20110082145A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
TW201206936A (en) 2010-07-19 2012-02-16 Alcon Res Ltd Methods and compositions for the treatment of allergy
TWI544922B (zh) * 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN103202833A (zh) * 2012-12-25 2013-07-17 常州市亚邦医药研究所有限公司 一种奥洛他定或其盐的药用组合物及其制备方法
CA2929074A1 (en) * 2013-10-31 2015-05-07 Nephron Pharmaceuticals Corporation Formulation of olopatadine
CN113985041A (zh) * 2021-09-29 2022-01-28 武汉钢铁有限公司 一种实验室检测设备精度控制的控制限的设定方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370324A (en) * 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤

Also Published As

Publication number Publication date
ATE220906T1 (de) 2002-08-15
EP0799044A2 (de) 1997-10-08
DE10299034I1 (de) 2003-01-23
DE69622527D1 (de) 2002-08-29
FI970489A7 (fi) 1997-02-05
JP3068858B2 (ja) 2000-07-24
US5641805A (en) 1997-06-24
DK0799044T3 (da) 2002-10-14
AU5726196A (en) 1996-12-24
MY116651A (en) 2004-03-31
NL300101I2 (nl) 2003-01-06
JPH09510235A (ja) 1997-10-14
DE10299034I2 (de) 2005-07-07
TW438588B (en) 2001-06-07
NO970517D0 (no) 1997-02-05
CA2195094C (en) 2002-02-26
NL300101I1 (nl) 2002-12-02
FI970489L (fi) 1997-02-05
DE69622527T2 (de) 2002-12-05
WO1996039147A3 (en) 1997-02-20
KR970704452A (ko) 1997-09-06
FI970489A0 (fi) 1997-02-05
MX9701013A (es) 1997-05-31
CN1082367C (zh) 2002-04-10
EP0799044B1 (de) 2002-07-24
NO970517L (no) 1997-04-03
CN1161000A (zh) 1997-10-01
ES2179198T3 (es) 2003-01-16
CA2195094A1 (en) 1996-12-12
AU698854B2 (en) 1998-11-12
LU90969I2 (fr) 2002-12-02
KR100202155B1 (ko) 1999-06-15
PT799044E (pt) 2002-11-29
WO1996039147A2 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
EP0799044B1 (de) Formulierung zur topischen anwendung am auge, die olopatadine enthalten, zur behandlung von allergischen augenerkrankungen
US4599353A (en) Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
TWI578990B (zh) 眼睛過敏之治療
CN1943577B (zh) (2-咪唑啉-2-基氨基)喹喔啉在制备用于治疗视神经损伤的药物中的应用
EP1037627B1 (de) Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation
Woodward et al. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva
US5196449A (en) Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
EP0673250A1 (de) Ophtalmische Zusammensetzungen enthaltenden Emedastine und ihre Verwendungzur Behandlung von allergischer Konjunktivitis
McLaren et al. Effect of ibopamine on aqueous humor production in normotensive humans
AU2008289347B2 (en) Compositions and methods for modulating endophthalmitis using fluoroquinolones
Friedlaender The current and future therapy of allergic conjunctivitis
US7589107B2 (en) Amelioration of vitrectomy-induced cataracts
TW200927169A (en) Complement Clq inhibitors for the prevention and treatment of glaucoma
JP2010047567A (ja) 加齢黄斑変性の予防又は治療剤
US6174914B1 (en) Method of inhibiting cytokine release from human ocular cells
US20110166126A1 (en) Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones
JPH10203982A (ja) 視機能障害の予防・治療剤
US20010006965A1 (en) Method for treating patients with diabetic retinopathy by administering substituted sulfonyl indenyl acetic acids and alcohols
WO2024163858A1 (en) Haloperidol derivatives, pharmaceutical composition comprising said derivatives, and therapeutic uses thereof
JP2017218384A (ja) 網膜疾患の予防または治療のための医薬組成物
HK1030362B (en) Use of 11-(3-dimethylaminopropylidene)-6, 11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization

Legal Events

Date Code Title Description
MK1K Patent expired